Caffeine metabolism by human hepatic cytochromes p450: Contributions of 1A2, 2E1 and 3A isoforms
- 18 May 1994
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 47 (10), 1767-1776
- https://doi.org/10.1016/0006-2952(94)90304-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolismBritish Journal of Clinical Pharmacology, 1993
- Caffeine as a probe for human cytochromes P450Pharmacogenetics, 1992
- Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1Pharmacogenetics, 1992
- Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoformsBiochemical Pharmacology, 1992
- Localization of CYP1A1 and CYP1A2 messenger RNA in normal human liver and in hepatocellular carcinoma by in situ hybridizationHepatology, 1991
- Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspectsChemical Research in Toxicology, 1991
- Activation of the food-derived mutagen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by rabbit and human liver microsomes and purified forms of cytochrome P-450Carcinogenesis: Integrative Cancer Research, 1989
- Theophylline Metabolism by Human, Rabbit and Rat Liver Microsomes and by Purified Forms of Cytochrome P450Journal of Pharmacy and Pharmacology, 1988
- Characterisation of theophylline metabolism by human liver microsomesBiochemical Pharmacology, 1988
- Biotransformation of caffeine by microsomes from human liverBiochemical Pharmacology, 1987